Your browser doesn't support javascript.
loading
Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial.
Lorenzatti, Alberto J; Eliaschewitz, Freddy G; Chen, Yundai; Lu, Juming; Baass, Alexis; Monsalvo, Maria Laura; Wang, Nan; Hamer, Andrew W; Ge, Junbo.
Afiliação
  • Lorenzatti AJ; Clinical Research and Cardiology, Instituto Medico DAMIC / Fundación Rusculleda, Córdoba, Argentina.
  • Eliaschewitz FG; CPCLIN - Centro de Pesquisas Clínicas, Rua Goias, São Paulo, Brazil.
  • Chen Y; Department of Cardiology, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Lu J; Department of Endocrinology, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Baass A; Department of Medicine, Royal Victoria Hospital, Montreal, Québec, Canada.
  • Monsalvo ML; Clinical Development, Amgen Inc., Thousand Oaks, California, USA.
  • Wang N; Clinical Development, Amgen Inc., Thousand Oaks, California, USA.
  • Hamer AW; Clinical Development, Amgen Inc., Thousand Oaks, California, USA.
  • Ge J; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Diabetes Obes Metab ; 21(6): 1455-1463, 2019 06.
Article em En | MEDLINE | ID: mdl-30821053
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Dislipidemias / Anticorpos Monoclonais Humanizados / Anticolesterolemiantes Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Argentina
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Dislipidemias / Anticorpos Monoclonais Humanizados / Anticolesterolemiantes Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Argentina